Cargando...
Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
BACKGROUND AND AIMS: Nalmefene has been approved in Europe for the treatment of alcohol dependence and subsequently recommended by the UK National Institute for Health and Care Excellence (NICE). This study examines critically the evidence base underpinning both decisions and the issues arising. MET...
Gardado en:
| Publicado en: | Addiction |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089629/ https://ncbi.nlm.nih.gov/pubmed/27262594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.13438 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|